Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

Hydrogel Formulations That Induce Dormancy in Breast Cancer Cells


详细技术说明

TechnologyDescription:Dr. Slater’s lab at the University of Delaware has developeda hydrogel formulation that allow long-term culture of cancer cells duringwhich the cells can be maintained in a dormant or quiescent state or in anactively proliferating state. The process is facile, easily replicable, andamenable to high-throughput assays, for both assessment of cellularcharacteristics and drug validation.Background &Applications:Metastasis isresponsible for 90% of cancer-associated mortality. Metastasized cells oftenlay in a dormant state for years, or even decades, before reverting to anactively proliferating state to form secondary tumors. Current cancertreatments do not treat dormant cells. Accordingly, there is much interest indeveloping therapeutics that treat dormant cancer cells but inducing dormancyand monitoring dormant cells in animal models in currently impossible. Toovercome this problem, we developed a tissue-engineered, in vitro platformthat allows us to induce both dormant and proliferative states in highlymetastatic breast cancer cells via tuning of the matrix properties. We envisiontwo main applications of this platform:·      Screening the efficacy of new therapeutics on treatmentof dormant cancer cells. ·      Development of new therapeutic targets to treat dormantcells.ProblemsAddressed:Most current invitro models of breast cancer recapitulate the metastatic and aggressivebehavior of cancer cells but not the dormant state associated with metastases.Current chemotherapeutics are effective in treating proliferating cells but donot dormant cells. Methods to induce a desired state (proliferative or dormant)in cancer cells still lacking. In the absence of such models, molecularcharacterization of dormant tumor cells is also challenging. This platformfacilitates discovery of both novel targets specific to dormant cancer cellsand validation of potential drug candidates against identified targets forfuture translation.


国家

United States


申请号码

Patent Pending


国家/地区

美国

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版